Pain control: opioid dosing, population kinetics and side-effects.
Neonates undergoing invasive procedures, postoperative pain or ventilatory support commonly receive opioids for treating pain and stress. Randomized clinical trials have examined the benefits and adverse effects of morphine or fentanyl for ventilated neonates and other indications. This paper summarizes the current evidence for opioid dosing in newborns, reviews their side-effects and explains the use of population kinetics and non-linear mixed-effects modeling to analyze the data from clinical trials. Opioid use should be reserved for severe pain postoperatively or during intensive care in neonates, using continuous infusions rather than intermittent boluses. The safety and efficacy data from prolonged opioid use, particularly on the long-term outcomes of neonates, is still lacking. The pharmacodynamics and pharmacogenetics of opioid use in infancy needs further investigation, using non-linear mixed-effects models to drive individualized therapy. The current interest in opioid research will reap rich dividends in providing pain relief for neonates and avoiding dangerous side effects.
Simons
Sinno H P
SH
Department of Pediatric Surgery, Erasmus-MC/Sophia Children's Hospital, Rotterdam, The Netherlands. sinnosimons@hotmail.com
Anand
K J S
KJ
D000701:Analgesics, Opioid / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal / Q000379:methods; D008657:Metabolic Clearance Rate; D009020:Morphine / Q000493:pharmacokinetics / Q000627:therapeutic use; D009359:Neonatology / Q000379:methods*; D010146:Pain / Q000188:drug therapy*; D010149:Postoperative Pain / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000139:chemically induced; D016896:Treatment Outcome
D000701:Analgesics, Opioid; D009020:Morphine